Company / Current Liabilities
Haemonetics Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$578.1M
FY2025
5-year range
$251.8M / $578.1M
FY2021-FY2025
Trend
+92.5%
vs FY2024
Sector context
#72 of 165
Health Care
What the data says
At $578M, Haemonetics's current liabilities ranks #94 of 165 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $186M in FY2016 to $578M in FY2025.
Based on SEC 10-K filings.
$578M in FY2025 with a 5-year CAGR of +16.0%.
Increased from $252M to $578M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Sector benchmark
#94 of 165 in Health CareTop 56% of 165This company $578.1M Sector average $4.4B
▼
-86.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.0%, indicating consistent growth.
- In FY2025, current liabilities increased 92.5% year-over-year.
- Ranks #72 out of 165 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $578.1M | +92.5% |
| FY2024 | $300.4M | +19.3% |
| FY2023 | $251.8M | -43.1% |
| FY2022 | $442.3M | +74.5% |
| FY2021 | $253.5M | -7.8% |
| FY2020 | $274.8M | +16.6% |
| FY2019 | $235.8M | -38.7% |
| FY2018 | $384.7M | +82.2% |
| FY2017 | $211.2M | +13.8% |
| FY2016 | $185.6M | -1.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026